Subscribe To
TALS / Talaris Therapeutics to Participate at Two Upcoming Investor Conferences
TALS News
By Seeking Alpha
August 29, 2022
Talaris Therapeutics: Plenty Of Upside Remains, But So Does The Risk
Shares of cell therapy concern Talaris Therapeutics crashed nearly 70% after GvHD outcomes in three Phase 3 trial kidney transplant patients were reve more_horizontal
By GlobeNewsWire
March 22, 2022
Talaris Therapeutics to Participate at Two Upcoming Investor Conferences
BOSTON and LOUISVILLE, Ky., March 22, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company d more_horizontal